Suppr超能文献

氯化噻吩基查耳酮的探索:一类新型单胺氧化酶-B抑制剂。

Exploration of chlorinated thienyl chalcones: A new class of monoamine oxidase-B inhibitors.

作者信息

Mathew Bijo, Haridas Abitha, Uçar Gülberk, Baysal Ipek, Adeniyi Adebayo A, Soliman Mahmoud E S, Joy Monu, Mathew Githa Elizabeth, Lakshmanan Baskar, Jayaprakash Venkatesan

机构信息

Division of Drug Design and Medicinal Chemistry Research Lab, Department of Pharmaceutical Chemistry, Ahalia School of Pharmacy, Palakkad 678557, Kerala, India.

Department of Pharmaceutical Chemistry, Grace College of Pharmacy, Palakkad 678004, Kerala, India.

出版信息

Int J Biol Macromol. 2016 Oct;91:680-95. doi: 10.1016/j.ijbiomac.2016.05.110. Epub 2016 Jun 1.

Abstract

Chalcone has been reported to be a valid scaffold for the design of monoamine oxidase (MAO) inhibitors. This scenario has amplified the momentum for the discovery of heteroaryl based chalcone MAO inhibitors. In the present study, we have synthesized a series of eleven chlorinated thienyl chalcone derivatives substituted with a different functional groups at the para- position on the ring B and investigated for their ability to inhibit human MAO-A and -B. With the exception of compound (2E)-1-(4-chlorocyclopenta-1,3-dien-1-yl)-3-(4-nitrophenyl)prop-2-en-1-one (TC7), which was a selective MAO-A inhibitor, all the other derivatives inhibited hMAO-B potently and selectively with competitive mode of inhibition. The most potent compound (2E)-1-(4-chlorocyclopenta-1,3-dien-1-yl)-3-(4-ethylphenyl)prop-2-en-1-one (TC6) was found to be the best activity and higher selectivity towards hMAO-B with Ki and SI values of 0.31±0.02μM and 16.84, respectively. All the compounds presented in the current study are completely non-toxic with 74-88% viable cells to hepatic cells at 100μM concentration. Molecular docking and molecular dynamics simulation studies were carried out using Autodock-4.2 and Amber 14 to understand the molecular level interaction and energy relation of MAO isoforms with selective MAO-B inhibitor TC6.

摘要

据报道,查尔酮是设计单胺氧化酶(MAO)抑制剂的有效骨架。这种情况推动了基于杂芳基的查尔酮MAO抑制剂的发现。在本研究中,我们合成了一系列11种在环B的对位带有不同官能团取代的氯化噻吩基查尔酮衍生物,并研究了它们抑制人MAO-A和-B的能力。除了化合物(2E)-1-(4-氯环戊-1,3-二烯-1-基)-3-(4-硝基苯基)丙-2-烯-1-酮(TC7)是一种选择性MAO-A抑制剂外,所有其他衍生物均以竞争性抑制模式有效且选择性地抑制hMAO-B。发现最有效的化合物(2E)-1-(4-氯环戊-1,3-二烯-1-基)-3-(4-乙基苯基)丙-2-烯-1-酮(TC6)具有最佳活性和对hMAO-B的更高选择性,其Ki和SI值分别为0.31±0.02μM和16.84。本研究中呈现的所有化合物在100μM浓度下对肝细胞完全无毒,有74-88%的活细胞。使用Autodock-4.2和Amber 14进行了分子对接和分子动力学模拟研究,以了解MAO同工型与选择性MAO-B抑制剂TC6的分子水平相互作用和能量关系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验